The HLA-A*31:01 allele: influence on carbamazepine treatment
about
The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions.HLAs: Key regulators of T-cell-mediated drug hypersensitivity.Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.
P2860
The HLA-A*31:01 allele: influence on carbamazepine treatment
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The HLA-A*31:01 allele: influence on carbamazepine treatment
@en
The HLA-A*31:01 allele: influence on carbamazepine treatment.
@nl
type
label
The HLA-A*31:01 allele: influence on carbamazepine treatment
@en
The HLA-A*31:01 allele: influence on carbamazepine treatment.
@nl
prefLabel
The HLA-A*31:01 allele: influence on carbamazepine treatment
@en
The HLA-A*31:01 allele: influence on carbamazepine treatment.
@nl
P2860
P356
P1476
The HLA-A*31:01 allele: influence on carbamazepine treatment
@en
P2093
Vincent Lai Ming Yip
P2860
P356
10.2147/PGPM.S108598
P577
2017-01-31T00:00:00Z